desethylchloroquine has been researched along with Lupus Erythematosus, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, W; Luo, X; Peng, Y | 1 |
| Charlier, B; Dal Piaz, F; Fasano, S; Filippelli, A; Iudici, M; Izzo, V; Pantano, I; Pierro, L; Pingeon, M | 1 |
| Amoura, Z; Combarel, D; Funck-Brentano, C; Lori, L; Noé, G; Seycha, A; Tissot, N; Zahr, N | 1 |
3 other study(ies) available for desethylchloroquine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
A Sensitive and Optimized HPLC-FLD Method for the Simultaneous Quantification of Hydroxychloroquine and Its Two Metabolites in Blood of Systemic Lupus Erythematosus Patients.
Topics: Adult; Chloroquine; Chromatography, High Pressure Liquid; Female; Humans; Hydroxychloroquine; Linear Models; Lupus Erythematosus, Systemic; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Young Adult | 2020 |
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.
Topics: Adult; Antirheumatic Agents; Chloroquine; Female; Health Status; Humans; Hydroxychloroquine; Immunosuppressive Agents; Italy; Lupus Erythematosus, Systemic; Male; Middle Aged; Patient Reported Outcome Measures; Quality of Life; Risk Factors; Self-Assessment; Severity of Illness Index; Treatment Adherence and Compliance | 2018 |
Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Topics: Antirheumatic Agents; Calibration; Chloroquine; Chromatography, High Pressure Liquid; Drug Monitoring; Fluorescence; Humans; Hydroxychloroquine; Indicators and Reagents; Lupus Erythematosus, Systemic; Reproducibility of Results | 2019 |